[Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003]

Med Mal Infect. 2005 Jun;35(6):329-34. doi: 10.1016/j.medmal.2005.05.002.
[Article in French]

Abstract

The French national observatory for epidemiology of bacterial resistance to antibiotics (ONERBA) includes numerous networks for the surveillance of bacterial resistance to antibiotics.

Objective: The aim of this study was to update antimicrobial resistance data of bacterial pathogens isolated from blood cultures.

Method: Data was collected from several surveillance surveys reviewed by the ONERBA scientific committee during 2003.

Results: Gram positive cocci and Gram negative bacilli accounted respectively for 45 and 49% of all bacteria isolated from blood cultures (N=19 882). The frequency of MRSA among S. aureus was 35%. The frequencies of resistance to penicillin, amoxicillin and cefotaxime of S. pneumoniae were 10, 2, and 0.2%, respectively. In 2002, 70% of coagulase negative staphylococci were resistant to methicillin. Only 50 and 60% of E. coli isolates were susceptible to aminopenicillin and a combination amoxicillin-clavulanic acid, respectively. Since 2001, the susceptibility of E. coli isolates to ciprofloxacin has been regularly decreasing. Imipenem and ceftazidime were the most active antimicrobial agents against P. aeruginosa with a susceptibility rates below 90%.

Conclusion: Data provided by the ONERBA should allow to improve the quality of empiric antimicrobial treatments.

Publication types

  • English Abstract

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteremia / epidemiology
  • Bacteremia / microbiology*
  • Bacteria / drug effects
  • Bacteria / isolation & purification*
  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / microbiology
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Drug Resistance, Bacterial*
  • Drug Resistance, Multiple, Bacterial
  • France / epidemiology
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / isolation & purification
  • Gram-Negative Bacterial Infections / epidemiology
  • Gram-Negative Bacterial Infections / microbiology
  • Gram-Positive Bacteria / drug effects
  • Gram-Positive Bacteria / isolation & purification
  • Gram-Positive Bacterial Infections / epidemiology
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • Microbial Sensitivity Tests
  • Population Surveillance
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents